Erratum to: Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same? Maria Ignez BraghiroliRachel P. RiechelmannPaulo M. Hoff Erratum 28 May 2014 Pages: 249 - 250
To HIPEC or Not to HIPEC? That Is The Question David P. Ryan INVITED COMMENTARY 27 July 2014 Pages: 251 - 253
Clinical End Points and Relevant Clinical Benefits in Advanced Colorectal Cancer Trials Margarita GarcíaValentín NavarroAna Clopés Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 14 May 2014 Pages: 254 - 262
Optimization of Anti-EGFR Treatment of Advanced Colorectal Cancer Loredana Vecchione Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 24 June 2014 Pages: 263 - 271
Optimization of Patient Selection for Surgical Approach to Peritoneal Metastases from Gastrointestinal Cancer Using Cytoreductive Surgery and Perioperative Chemotherapy Paul H. Sugarbaker Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 10 May 2014 Pages: 272 - 278
Optimization of the Development of Old and New EGFR and MAP Kinase Inhibitors for Colorectal Cancer Erika MartinelliStefania NapolitanoTeresa Troiani Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 27 June 2014 Pages: 279 - 287
New Targets and New Drug Development in Colorectal Cancer Ana C. Garrido-CastroTamara Sauri-NadalTeresa Macarulla-Mercadé Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 17 August 2014 Pages: 288 - 295
Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence Tom Treasure Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) Open access 27 August 2014 Pages: 296 - 302
Oxaliplatin Neurotoxicity Roser VelascoJordi Bruna Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor) 18 June 2014 Pages: 303 - 312
Adjuvant HIPEC in Colorectal Cancer Dominique ÉliasAlexis-Simon CloutierDiane Goéré Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors) 16 April 2014 Pages: 313 - 320
Update on the Colon Health and Life-Long Exercise Change Trial: A Phase III Study of the Impact of an Exercise Program on Disease-Free Survival in Colon Cancer Survivors Kerry S. CourneyaJanette VardyChristopher M. Booth Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors) 13 June 2014 Pages: 321 - 328
Accuracy of Predefined Hypotheses in Colon Cancer Adjuvant Phase III Trials: Observations and Recommendations Aimery de GramontBenoist ChibaudelThierry André Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors) 21 August 2014 Pages: 329 - 338
Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence? Kimmie Ng Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors) 27 June 2014 Pages: 339 - 345
Prognostic Impact of Deficient DNA Mismatch Repair and KRAS and BRAF V600E Mutations in Patients with Lymph-Node-Positive Colon Cancer Aziz ZaananJean-Baptiste BachetFrank A. Sinicrope Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors) 29 June 2014 Pages: 346 - 353
Adjuvant Therapy in Combination with Resection of Colorectal Cancer Metastasis to the Liver or Lungs Antoine BrouquetBernard Nordlinger ADJUVANT THERAPY FOR COLON CANCERS (AB BENSON III AND A DE GRAMONT, SECTION EDITORS) 07 August 2014 Pages: 354 - 361
